4 unknown, 3 completed, 2 terminated. 6 Phase 1, 5 Phase 2, 2 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 6 | Unknown 3, Completed 2, Terminated 1 |
| Phase 2 | 5 | Completed 2, Unknown 2, Terminated 1 |
| Phase 3 | 2 | Terminated 1, Unknown 1 |
Follow Poniard Pharmaceuticals: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Cardiac Safety Assessment Study of Picoplatin in Solid Tumors Picoplatin - Solid Tumors | Phase 1 | Unknown | Poniard Pharmaceuticals | 40 | 2008-06-01 | 2009-09-24 |
| Study of Picoplatin Efficacy After Relapse picoplatin, best supportive care - Small Cell Lung Cancer | Phase 3 | Unknown | Poniard Pharmaceuticals | 399 | 2007-04-01 | 2009-04-14 |
| A Study Comparing Oral Picoplatin With Intravenous Picoplatin in Subjects With Solid Tumors Picoplatin - Bladder Cancer, Breast Cancer | Phase 1 | Completed | Poniard Pharmaceuticals | 18 | 2007-04-01 | 2009-09-24 |
| A Study of Picoplatin and Docetaxel in Subjects With Prostate Cancer Picoplatin, docetaxel - Hormone Refractory Prostate Cancer | Phase 1 / Phase 2 | Unknown | Poniard Pharmaceuticals | 95 | 2006-06-01 | 2009-01-21 |
| A Study of Picoplatin in Colorectal Cancer (FOLPI) Picoplatin with 5-FU and Leucovorin, FOLPI, FOLFOX - Colorectal Cancer | Phase 1 / Phase 2 | Unknown | Poniard Pharmaceuticals | 43 | 2006-04-01 | 2009-01-21 |
| Picoplatin as Second-Line Therapy for Patients With Small Cell Lung Cancer picoplatin - Small Cell Lung Cancer | Phase 2 | Completed | Poniard Pharmaceuticals | 75 | 2005-06-01 | 2009-01-21 |
| Study Comparing STR (Skeletal Targeted Radiotherapy) Plus Melphalan to Melphalan Alone, With Stem Cell Transplant in Multiple Myeloma STR(TM) (Skeletal Targeted Radiotherapy, Holmium-166-DOTMP) - Multiple Myeloma | Phase 3 | Terminated | Poniard Pharmaceuticals | 240 | 2004-03-01 | 2009-03-31 |
| A Trial of Skeletal Targeted Radiotherapy Using Holmium-166-DOTMP in Patients With Multiple Myeloma Holmium-166-DOTMP - Multiple Myeloma | Phase 1 / Phase 2 | Terminated | Poniard Pharmaceuticals | 2002-03-01 | 2009-01-21 | |
| Chemotherapy, Holmium Ho 166 DOTMP, and Peripheral Stem Cell Transplantation in Treating Patients With Multiple Myeloma melphalan, peripheral blood stem cell transplantation, holmium Ho 166 DOTMP - Multiple Myeloma and Plasma Cell Neoplasm | Phase 1 / Phase 2 | Completed | Poniard Pharmaceuticals | 2002-01-01 | 2009-04-03 |
Colorectal Neoplasms (3) · Multiple Myeloma (3) · Breast Neoplasms (2) · Gastrointestinal Neoplasms (2) · Head and Neck Neoplasms (2) · Lung Neoplasms (2) · Ovarian Neoplasms (2) · Pancreatic Neoplasms (2) · Prostatic Neoplasms (2) · Small Cell Lung Carcinoma (2) · Urinary Bladder Neoplasms (2) · Hypersensitivity (1) · Neoplasm Metastasis (1) · Neoplasms (1) · Neoplasms, Plasma Cell (1)
amminedichloro(2-methylpyridine)platinum(II) (6) · holmium-1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetrakis(methylenephosphonic acid) (3) · Docetaxel (1) · Fluorouracil (1) · Folfox protocol (1) · Leucovorin (1) · Melphalan (1) · Peripheral Blood Stem Cell Transplantation (1)
United States (5) · Russia (4) · Canada (2) · Argentina (1) · Belarus (1) · Bosnia and Herzegovina (1) · Bulgaria (1) · Chile (1) · Croatia (1) · Hungary (1) · India (1) · Latvia (1) · Montenegro (1) · Poland (1) · Romania (1)
Robert Earhart, MD, PhD (3) · David Karlin, MD (1) · Dr. Hazel Breitz, M.D. (1) · Hazel Breitz, MD (1) · Paul Weiden, MD (1) · Robert Earhart, MD (1) · Wendy Jenkins (1)